Loading clinical trials...
Loading clinical trials...
MT2017-17:T Cell Receptor Alpha/Beta T Cell Depleted Hematopoietic Cell Transplantation in Patients With Inherited Bone Marrow Failure (BMF) Disorders
Conditions
Interventions
Total Body Irradiation (TBI) (Plan 1)
Cyclophosphamide (CY) (Plan 1)
+10 more
Locations
1
United States
Masonic Cancer Center at University of Minnesota
Minneapolis, Minnesota, United States
Start Date
November 13, 2018
Primary Completion Date
January 1, 2027
Completion Date
January 5, 2029
Last Updated
January 30, 2026
NCT06303193
NCT06847867
NCT06465953
NCT05012111
NCT05636514
NCT03520647
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions